Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.76 |
| ▸ | ANPEP | P15144 | 2/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | LAP3 | P28838 | 3/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Phenylalaninol SCHEMBL2521 | 1.00 | EPHX1 (0.76) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL7422483 | 1.00 | EPHX1 (0.76) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL177073 | 1.00 | EPHX1 (0.76) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL87692 | 1.00 | EPHX1 (0.76) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL31229492 | 0.98 | EPHX1 (0.73) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL15467495 | 0.98 | EPHX1 (0.73) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL7252746 | 0.98 | EPHX1 (0.73) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL30996912 | 0.98 | EPHX1 (0.73) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL27430394 | 0.98 | EPHX1 (0.73) | EPHX1ANPEPSLC6A2TAAR1MAOA | |
| L-Phenylalaninol SCHEMBL27521331 | 0.98 | EPHX1 (0.73) | EPHX1ANPEPSLC6A2TAAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3343 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138972-A1 | PREPARATION METHOD AND CHIRAL SIEVING APPLICATION OF NOVEL 12-CROWN-4 COVALENT ORGANIC FRAMEWORKS | CHONGQING UNIV OF ARTS AND SCIENCES (CN) | 2026-05-21 | — | — | US | claimed |
| US-12534571-B2 | Amphiphilic block copolymer, preparation method thereof and nanomicelle drug-loading system | SHANGHAI BEST-LINK BIOSCIENCE, LLC (CN) | 2026-01-27 | — | — | US | claimed |
| WO-2025133248-A1 | DIASTEREOMERIC AMINOALCOHOL AND AMINOETHER SALTS OF 2-[(4R,S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-3,4-DIHYDROQUINAZOLIN-4-YL]ACETIC ACID AND THEIR USE FOR ENANTIOMERIC SEPARATION | AIC246 AG & CO. KG (DE) | 2025-06-26 | — | — | WO | claimed |
| CN-116640319-B | Organic chiral supermolecular gel based on 1-naphthylmethyl amine and application thereof in chiral recognition | 常州大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120025542-A | Non-isocyanate polyurethane and multicomponent selective synthesis method thereof | 华南理工大学 | 2025-05-23 | — | — | CN | claimed |
| WO-2025104679-A1 | PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-22 | — | — | WO | claimed |
| US-20250135005-A1 | PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES | TAMBO INC (US) | 2025-05-01 | — | — | US | claimed |
| CN-119899373-A | (-) -Gossypol derivative and preparation method thereof and antioxidant | 武汉轻工大学 | 2025-04-29 | — | — | CN | claimed |
| CN-119823023-A | Process for preparing functionalized cyclooctenes | 坦博公司 | 2025-04-15 | — | — | CN | claimed |
| US-12234208-B2 | 3,4-dihydroxy-n-(1′-benzyl-2′-hydroxyethyl)-2-methylpyridine chloride, and synthesis and use thereof | HANGZHOU ZEDE PHARMA-TECH CO. LTD. (CN) | 2025-02-25 | — | — | US | claimed |
| EP-0449884-A4 | DERIVATIVES OF TETRAPEPTIDES AS CCK AGONISTS | — | 1991-10-30 | — | — | EP | claimed |
| EP-0449884-A1 | DERIVATIVES OF TETRAPEPTIDES AS CCK AGONISTS | ABBOTT LABORATORIES (US) | 1991-10-09 | — | — | EP | claimed |
| WO-1991001370-A1 | PROTECTION OF NK CELL CYTOLYTIC ACTIVITY IN PBMC | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-02-07 | — | — | WO | claimed |
| US-4978744-A | Synthesis of dolastatin 10 | ARIZONA BOARD OF REGENTS (US) | 1990-12-18 | — | — | US | claimed |
| WO-1989010916-A1 | ENANTIOSELECTIVE ADDITION OF HYDROCARBONS TO ALPHA,BETA-UNSATURATED CARBONYL COMPOUNDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-11-16 | — | — | WO | claimed |
| EP-0105696-B1 | OPTICALLY ACTIVE N-SUBSTITUTED PHENYLALANINOLS AND USE THEREFOR | Dainippon Pharmaceutical Co., Ltd. (JP) | 1986-01-02 | — | — | EP | claimed |
| US-4536601-A | USE FOR RESOLUTION OF D-3-ACETHYLTHIO-2-METHYLPROPIONIC ACID | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1985-08-20 | — | — | US | claimed |
| EP-0124388-A1 | Strain of Trichoderma harzianum, process for its isolation, process for its culture, peptides or compounds produced by this strain and application of this strain and these peptides or the product produced by the culture process as a means for biological control in the form of a phytosanitary product | LES PRODUITS ORGANIQUES DU SANTERRE ORSAN (FR) | 1984-11-07 | — | — | EP | claimed |
| EP-0105696-A1 | Optically active N-substituted phenylalaninols and use therefor | Dainippon Pharmaceutical Co., Ltd. (JP) | 1984-04-18 | — | — | EP | claimed |
| US-4014895-A | Method for synthesis of optically active thiolactones | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-03-29 | — | — | US | claimed |